Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q1- Text added to 2022 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
Africa, allot, amicably, article, asymptomatic, attorney, attributable, Biodiagnostic, brought, Canonico, CATK, CDC, China, conveye, correlation, counsel, Court, discovery, Donald, Eric, Eurosurveillance, exploring, Foundation, gynecologic, half, Hodson, immunocompromised, inclusive, intense, intervention, investigational, journal, lawsuit, lesion, liable, litigated, Merkakein, molecular, monetary, MonkeyPox, motion, motopara, Nihul, past, Percent, perpetual, prognostic, proteomic, protocol, published, pursuit, Quick, repossession, saleable, sample, sampling, seize, settle, sheriff, stage, Supreme, Tecovirimat, TPOXX, understanding, unknown, written
Valuein 2022 Q1 filing- Value in 2022 Q2 filing
Original filings
Filing view